What's new in total hip arthroplasty

Journal of Bone and Joint Surgery

Volumn 93, Issue 20, 2011, Pages 1944-1950

  Huo, Michael H ^a   Dumont, Guillaume D ^a   Knight, Justin R ^a   Mont, Michael A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; FENTANYL; NARCOTIC AGENT; PARACETAMOL; PREGABALIN;

BLOOD CONSERVATION; HUMAN; MEDICAL PRACTICE; OUTCOME ASSESSMENT; PATIENT CONTROLLED ANALGESIA; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROSTHESIS INFECTION; REVIEW; TOTAL HIP PROSTHESIS; VENOUS THROMBOEMBOLISM;

EID: 80054869987     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.K.00656     Document Type: Review

References (49)

1. Skinner J, Gie G, Kay P. Metal on metal hip replacement and hip resurfacing arthroplasty: what does the MHRA medical device alert mean? British Hip Society newsletter. July 2010.http://www.britishhipsociety.com/docs/ Newsletter%20July%202010.pdf. Accessed 2011 Jul 22.
2. American Academy of Orthopaedic Surgeons.Metal-on-metal hip replacement. 2010 Oct 29. http://www6.aaos.org/news/pemr/releases/release.cfm?releasenum=934. Accessed 2011 Jul 22.
3. The American Association of Hip and Knee Surgeons, The Hip Society and the American Academy of Orthopaedic Surgeons. Information for our patients regarding metal-on-metal (MoM) hip replacements. http://www.hipsoc.org/web/ MoM%20Q%20A%2012-14-final.pdf. Accessed 2011 Jul 22.
4. The U.S. Food and Drug Administration. Metal-on-metal hip implants. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ ImplantsandProsthetics/MetalonMetalHipImplants/default.htm. Accessed 2011 Jul 22.
5. McGrory B, Barrack R, Lachiewicz PF, Schmalzried TP, Yates AJ Jr, Watters WC 3rd, Turkelson CM, Wies JL, St Andre J. Modern metal-on-metal hip resurfacing. J Am Acad Orthop Surg. 2010;18:306-14.
6. van der Weegen W, Hoekstra HJ, Sijbesma T, Bos E, Schemitsch EH, Poolman RW. Survival of metal-on-metal hip resurfacing arthroplasty: a systematic review of the literature. J Bone Joint Surg Br. 2011;93:298-306.
7. Bozic KJ, Ong K, Lau E, Kurtz SM, Vail TP, Rubash HE, Berry DJ. Risk of complication and revision total hip arthroplasty among Medicare patients with different bearing surfaces. Clin Orthop Relat Res. 2010;468:2357-62.
8. Amstutz HC, Le Duff MJ, Campbell PA, Gruen TA, Wisk LE. Clinical and radiographic results of metal-on-metal hip resurfacing with a minimum ten-year follow-up. J Bone Joint Surg Am. 2010;92:2663-71.
9. Treacy RB, McBryde CW, Shears E, Pynsent PB. Birmingham hip resurfacing: a minimum follow-up of ten years. J Bone Joint Surg Br. 2011;93:27-33.
10. Grimes JB. Reclassification of metal-metal bearings based on operational clearance. In: Proceedings of 56th Annual Meeting of the Orthopaedic Research Society; 2010 March 6-9; New Orleans, Louisiana.
11. Hart A, Underwood R, Cann P, Ilo K, Matthies A, Cobb JP, Muirhead-Allwood S, Porter M, Skinner J. Clinical and wear analysis of 276 failed large diameter metal-on-metal hip components. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
12. Hart AJ, Ilo K, Underwood R, Cann P, Henckel J, Lewis A, Cobb J, Skinner J. The relationship between the angle of version and rate of wear of retrieved metal-on-metal resurfacings: a prospective, CT-based study. J Bone Joint Surg Br. 2011;93:315-20.
13. Tiberi JV, Billi F, Kertzner M, Dela Rosa MA, Schmalzried TP. Outcomes and pathomechanics of adverse local tissue reactions (ALTR) in metal-metal bearings. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
14. Ball ST, Meyer RS, Campbell PA, Bugbee W, Hillman J, Boyle D, Firestein GS. Inflammatory cytokines are elevated in patients with adverse reactions to metal-on-metal THA's. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
15. Garbuz DS, Williams D, Greidanus NV, Masri BA, Duncan CP. Serum metal ion and ultrasound assessment of asymptomatic metal-on-metal hip replacement. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
16. Stulberg BN, Zadzilka JD, Milbrandt JC, Allan DG, Helmy HF, Jacobs MA, Kennedy WR, Prifti D. Serum cobalt and chromium levels after metal-on-metal hip resurfacing: minimum 5 year analysis. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
17. Ebramzadeh E, Campbell PA, Lu Z, Takamura KM, Amstutz HC, DeSmet KA. Failure causes and modes of modern metal-on-metal hip resurfacing implants. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
18. Barnett CD, Peters CL, Erikson J, McPherson EJ, Lombardi AV Jr, Berend KR. Short-term results of large diameter metal on metal total hip arthroplasty. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
19. Barrett WP, Kindsfater K, Lesko J. Large diameter modular metal-on-metal total hips: assessing soft tissue adverse events. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
20. Langton D, Joyce T, Natu S, Tulloch C, Logishetty R, Cooke N, Nargol A. Volumetric wear of MoM hips does not correlate with extent of tissue destruction at revision. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
21. Huber M, Reinisch G, Zenz P, Zweymüller K, Lintner F. Postmortem study of femoral osteolysis associated with metal-on-metal articulation in total hip replacement: an analysis of nine cases. J Bone Joint Surg Am. 2010;92:1720-31.
22. Bartelt RB, Yuan BJ, Trousdale RT, Sierra RJ. The prevalence of groin pain after metal-on-metal total hip arthroplasty and total hip resurfacing. Clin Orthop Relat Res. 2010;468:2346-56.
23. Grammatopoulos GA, Langton D, Backers K, Pandit HG, Taylor A, Glyn-Jones S, DeSmet KA, Murray DW, Gill RHS. Neck narrowing in hip resurfacing is associated with wear. Read at the Annual Meeting of the American Academy of Orthopaedic Surgeons; 2011 Feb 15-19; San Diego, CA.
24. Bozic KJ. Femoral and acetabular component utilization in the United States. Read at the Annual Meeting of the Hip Society; 2011 Feb 19; San Diego, California.
25. Bozic KJ, Maselli J, Pekow PS, Lindenauer PK, Vail TP, Auerbach AD. The influence of procedure volumes and standardization of care on quality and efficiency in total joint replacement surgery. J Bone Joint Surg Am. 2010;92:2643-52.
26. Lu X, Hagen TP, Vaughan-Sarrazin MS, Cram P. The impact of new hospital orthopaedic surgery programs on total joint arthroplasty utilization. J Bone Joint Surg Am. 2010;92:1353-61.
27. Ong KL, Lau E, Suggs J, Kurtz SM, Manley MT. Risk of subsequent revision after primary and revision total joint arthroplasty. Clin Orthop Relat Res. 2010;468:3070-6.
28. Jafari SM, Coyle C, Mortazavi SM, Sharkey PF, Parvizi J. Revision hip arthroplasty: infection is the most common cause of failure. Clin Orthop Relat Res. 2010;468:2046-51.
29. Babis GC, Sakellariou VI, O'Connor MI, Hanssen AD, Sim FH. Proximal femoral allograft-prosthesis composites in revision hip replacement: a 12-year follow-up study. J Bone Joint Surg Br. 2010;92:349-55.
30. Weiss RJ, Beckman MO, Enocson A, Schmalholz A, Stark A. Minimum 5-year follow-up of a cementless, modular, tapered stem in hip revision arthroplasty. J Arthroplasty. 2011;26:16-23.
31. Lakstein D, Eliaz N, Levi O, Backstein D, Kosashvili Y, Safir O, Gross AE. Fracture of cementless femoral stems at the mid-stem junction in modular revision hip arthroplasty systems. J Bone Joint Surg Am. 2011;93:57-65.
32. Parvizi J, Pour AE, Hillibrand A, Goldberg G, Sharkey PF, Rothman RH. Back pain and total hip arthroplasty: a prospective natural history study. Clin Orthop Relat Res. 2010;468:1325-30.
33. Kim SH. Morbid obesity and excessive hospital resource consumption for unilateral primary hip and knee arthroplasty. J Arthroplasty. 2010;25:1258-66.
34. Higuera CA, Elsharkawy K, Klika AK, Brocone M, Barsoum WK. 2010 Mid-America Orthopaedic Association Physician in Training Award: predictors of early adverse outcomes after knee and hip arthroplasty in geriatric patients. Clin Orthop Relat Res. 2011;469:1391-400.
35. SooHoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res. 2010;468:2363-71.
36. Parvizi J, Suh DH, Jafari SM, Mullan A, Purtill JJ. Aseptic loosening of total hip arthroplasty: infection always should be ruled out. Clin Orthop Relat Res. 2011;469:1401-5.
37. Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, Murad MH, Steckelberg J, Osmon D. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am. 2010;92:2102-9.
38. Azzam KA, Seeley M, Ghanem E, Austin MS, Purtill JJ, Parvizi J. Irrigation and debridement in the management of prosthetic joint infection: traditional indications revisited. J Arthroplasty. 2010;25:1022-7.
39. Oussedik SI, Dodd MB, Haddad FS. Outcomes of revision total hip replacement for infection after grading according to a standard protocol. J Bone Joint Surg Br. 2010;92:1222-6.
40. Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP. Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection? Clin Orthop Relat Res. 2011:469:1009-15.
41. Parvizi J, Pawasarat IM, Azzam KA, Joshi A, Hansen EN, Bozic KJ. Periprosthetic joint infection: the economic impact of methicillin-resistant infections. J Arthroplasty. 2010;25(Suppl 6):103-7.
42. Johnson AJ, Daley JA, Zywiel MG, Delanois RE, Mont MA. Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty. J Arthroplasty. 2010;25(Suppl 6):98-102.
43. Hooper GJ, Rothwell AG, Frampton C, Wyatt MC. Does the use of laminar flow and space suits reduce early deep infection after total hip and knee replacement? The ten-year results of the New Zealand Joint Registry. J Bone Joint Surg Br. 2011;93:85-90.
44. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010;92:2156-64.
45. Barsoum WK, Klika AK, Murray TG, Higuera C, Lee HH, Krebs VE. Prospective randomized evaluation of the need for blood transfusion during primary total hip arthroplasty with use of a bipolar sealer. J Bone Joint Surg Am. 2011;93:513-8.
46. Ralley FE, Berta D, Binns V, Howard J, Naudie DD. One intraoperative dose of tranexamic acid for patients having primary hip or knee arthroplasty. Clin Orthop Relat Res. 2010;468:1905-11.
47. Anakwe RE, Jenkins PJ, Moran M. Predicting dissatisfaction after total hip arthroplasty: a study of 850 patients. J Arthroplasty. 2011;26:209-13.
48. Post ZD, Restrepo C, Kahl LK, van de Leur T, Purtill JJ, Hozack WJ. A prospective evaluation of 2 different pain management protocols for total hip arthroplasty. J Arthroplasty. 2010;25:410-5.
49. Busch CA, Whitehouse MR, Shore BJ, MacDonald SJ, McCalden RW, Bourne RB. The efficacy of periarticular multimodal drug infiltration in total hip arthroplasty. Clin Orthop Relat Res. 2010;468:2152-9.